Home LiteratureArticle Details
PMID: 17267521 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.

Brain : a journal of neurology ·Vol. 130 ·No. Pt 3 ·2007-03-00 ·Pages 708-19

Whitwell JL, Weigand SD, Shiung MM, Boeve BF, Ferman TJ, Smith GE, Knopman DS, Petersen RC, Benarroch EE, Josephs KA, Jack CR

Abstract

Dementia with Lewy bodies (DLB) is the second most common cause of degenerative dementia after Alzheimer's disease. However, unlike the latter, the patterns of cerebral atrophy associated with DLB have not been well established. The aim of this study was to identify a signature pattern of cerebral atrophy in DLB and to compare it with the pattern found in Alzheimer's disease. Seventy-two patients that fulfilled clinical criteria for probable DLB were age- and gender-matched to 72 patients with probable Alzheimer's disease and 72 controls. Voxel-based morphometry (VBM) was used to assess patterns of grey matter (GM) atrophy in the two patient groups, relative to controls, after correction for multiple comparisons (P < 0.05). Study-specific templates and prior probability maps were used to avoid normalization and segmentation bias. Region-of-interest (ROI) analyses were also performed comparing loss of the midbrain, substantia innominata (SI), temporoparietal cortex and hippocampus between the groups. The DLB group showed very little cortical involvement on VBM with regional GM loss observed primarily in the dorsal midbrain, SI and hypothalamus. In comparison, the Alzheimer's disease group showed a widespread pattern of GM loss involving the temporoparietal association cortices and the medial temporal lobes. The SI and dorsal midbrain were involved in Alzheimer's disease; however, they were not identified as a cluster of loss discrete from uninvolved surrounding areas, as observed in the DLB group. On direct comparison between the two groups, the Alzheimer's disease group showed greater loss in the medial temporal lobe and inferior temporal regions than the DLB group. The ROI analysis showed reduced SI and midbrain GM in both patient groups, with a trend for more reduction of SI GM in Alzheimer's disease than DLB, and more reduction of midbrain in DLB than Alzheimer's disease. Significantly greater loss in the hippocampus and temporo-parietal cortex was observed in the Alzheimer's disease patients when the two patient groups were compared. A pattern of relatively focused atrophy of the midbrain, hypothalamus and SI, with a relative sparing of the hippocampus and temporoparietal cortex is, therefore, suggestive of DLB and this may aid in the differentiation of DLB from Alzheimer's disease. These findings support recent pathological studies showing an ascending pattern of Lewy body progression from brainstem to basal areas of the brain. Damage to this network of structures in DLB may affect a number of different neurotransmitter systems which in turn may contribute to a number of the core clinical features of DLB.

MeSH Terms
Aged Aged, 80 and over Alzheimer Disease/pathology Atrophy Brain/pathology Cerebral Cortex/pathology Diagnosis, Differential Female Hippocampus/pathology Humans Imaging, Three-Dimensional/methods Lewy Body Disease/pathology Magnetic Resonance Imaging/methods Male Mesencephalon/pathology Middle Aged Prospective Studies Substantia Innominata/pathology
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Whitwell Jennifer L
Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
Weigand Stephen D
Shiung Maria M
Boeve Bradley F
Ferman Tanis J
Smith Glenn E
Knopman David S
Petersen Ronald C
Benarroch Eduardo E
Josephs Keith A
Jack Clifford R
References (80)
80 references, click to expand
  1. Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB).
    Neuroreport. 1999 Jun 23;10(9):1903-7 PMID: 10501530
  2. Contributions of functional imaging to understanding parkinsonian symptoms.
    Curr Opin Neurobiol. 2004 Dec;14(6):715-9 PMID: 15582373
  3. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Neurology. 2005 Mar 8;64(5):861-5 PMID: 15753423
  4. Differences in MR features of the substantia innominata between dementia with Lewy bodies and Alzheimer's disease.
    J Neurol. 2005 Apr;252(4):482-4 PMID: 15772744
  5. Cholinesterase inhibitors in the treatment of dementia.
    J Am Osteopath Assoc. 2005 Mar;105(3):145-58 PMID: 15863734
  6. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Parkinsonism Relat Disord. 2005 Jun;11 Suppl 1:S47-51 PMID: 15885629
  7. Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease.
    Neuroimage. 2005 Jun;26(2):600-8 PMID: 15907317
  8. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study.
    Brain. 2005 Jul;128(Pt 7):1595-604 PMID: 15817515
  9. Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies.
    Psychiatry Res. 2005 Jul 30;139(2):79-88 PMID: 15964748
  10. Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine.
    Neurology. 2005 Aug 9;65(3):481-2 PMID: 16087923
  11. The use of memantine in dementia with Lewy bodies.
    J Alzheimers Dis. 2005 Aug;7(4):285-9 PMID: 16131729
  12. Evolution of the neuropathology of Alzheimer's disease.
    Acta Neurol Scand Suppl. 1996;165:3-12 PMID: 8740983
  13. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study.
    Brain. 1996 Dec;119 ( Pt 6):2001-7 PMID: 9010004
  14. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.
    Neurology. 1997 Sep;49(3):786-94 PMID: 9305341
  15. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease.
    Ann Neurol. 1998 Jan;43(1):102-6 PMID: 9450774
  16. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases.
    Neurology. 1998 Feb;50(2):388-91 PMID: 9484359
  17. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study.
    Neurology. 1998 Aug;51(2):357-62 PMID: 9710003
  18. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Brain. 2005 Nov;128(Pt 11):2626-44 PMID: 16014654
  19. A systematic review of prevalence and incidence studies of dementia with Lewy bodies.
    Age Ageing. 2005 Nov;34(6):561-6 PMID: 16267179
  20. Exacerbation of Lewy bodies dementia due to memantine.
    J Alzheimers Dis. 2005 Dec;8(3):289-91 PMID: 16340086
  21. Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies.
    Neurobiol Dis. 2006 Jan;21(1):50-6 PMID: 16023355
  22. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
    Neurology. 2005 Dec 27;65(12):1863-72 PMID: 16237129
  23. Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies.
    J Neurosci. 2006 Jan 11;26(2):467-78 PMID: 16407544
  24. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.
    Acta Neuropathol. 2006 Feb;111(2):109-14 PMID: 16421740
  25. REM sleep behavior disorder: a possible early marker for synucleinopathies.
    Neurology. 2006 Mar 28;66(6):796-7 PMID: 16567693
  26. Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB.
    Neurology. 2006 Mar 28;66(6):935-7 PMID: 16567718
  27. A putative flip-flop switch for control of REM sleep.
    Nature. 2006 Jun 1;441(7093):589-94 PMID: 16688184
  28. Neuropsychological differentiation of dementia with Lewy bodies from normal aging and Alzheimer's disease.
    Clin Neuropsychol. 2006 Dec;20(4):623-36 PMID: 16980250
  29. Visual hallucinations in posterior cortical atrophy.
    Arch Neurol. 2006 Oct;63(10):1427-32 PMID: 17030659
  30. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
    Int J Neuropsychopharmacol. 2007 Apr;10(2):231-44 PMID: 16448581
  31. MR features of the substantia innominata and therapeutic implications in dementias.
    Neurobiol Aging. 2007 Apr;28(4):548-54 PMID: 16569466
  32. New developments in the pathology of Parkinson's disease.
    Adv Neurol. 1990;53:1-16 PMID: 1978509
  33. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease.
    Neurology. 1992 Jan;42(1):183-8 PMID: 1734300
  34. Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.
    J Neurol Sci. 1991 Nov;106(1):50-5 PMID: 1779239
  35. Morphometric study on the CH4 of the nucleus basalis of Meynert in Alzheimer's disease.
    Mol Chem Neuropathol. 1991 Dec;15(3):193-206 PMID: 1725482
  36. Disease-specific patterns of locus coeruleus cell loss.
    Ann Neurol. 1992 Nov;32(5):667-76 PMID: 1449247
  37. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies.
    Neurology. 1993 Oct;43(10):1927-34 PMID: 8105420
  38. MRI-based hippocampal volume measurements in epilepsy.
    Epilepsia. 1994;35 Suppl 6:S21-9 PMID: 8206012
  39. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.
    Neuroreport. 1994 Mar 21;5(7):747-9 PMID: 8018843
  40. MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia.
    Neurology. 2000 Mar 28;54(6):1304-9 PMID: 10746602
  41. Voxel-based morphometry--the methods.
    Neuroimage. 2000 Jun;11(6 Pt 1):805-21 PMID: 10860804
  42. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.
    Lancet. 2000 Dec 16;356(9247):2031-6 PMID: 11145488
  43. Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2001 Feb;70(2):157-64 PMID: 11160462
  44. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study.
    Dement Geriatr Cogn Disord. 2001 May-Jun;12(3):198-205 PMID: 11244213
  45. Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images.
    Lancet. 2001 Jul 21;358(9277):201-5 PMID: 11476837
  46. Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI.
    Neurology. 2001 Dec 11;57(11):2117-20 PMID: 11739838
  47. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.
    Brain. 2002 Feb;125(Pt 2):391-403 PMID: 11844739
  48. Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia.
    J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):406-7 PMID: 11861709
  49. Thalamic gray matter changes in unilateral Parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging.
    Neurosci Lett. 2002 Apr 19;323(1):29-32 PMID: 11911983
  50. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.
    Arch Gen Psychiatry. 2002 Oct;59(10):946-51 PMID: 12365882
  51. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry.
    Neuroimage. 2002 Oct;17(2):618-30 PMID: 12377138
  52. Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies.
    Dement Geriatr Cogn Disord. 2002;14(4):167-75 PMID: 12411758
  53. Automatic differentiation of anatomical patterns in the human brain: validation with studies of degenerative dementias.
    Neuroimage. 2002 Sep;17(1):29-46 PMID: 12482066
  54. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.
    Neurology. 2003 May 27;60(10):1586-90 PMID: 12771246
  55. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.
    Dement Geriatr Cogn Disord. 2003;16(2):57-63 PMID: 12784028
  56. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study.
    Neurology. 2003 Nov 11;61(9):1191-5 PMID: 14610119
  57. Dementia with Lewy bodies.
    Lancet Neurol. 2004 Jan;3(1):19-28 PMID: 14693108
  58. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging.
    Neurology. 2004 Jan 27;62(2):181-7 PMID: 14745051
  59. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Brain. 2004 Apr;127(Pt 4):791-800 PMID: 14749292
  60. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Brain. 2004 Apr;127(Pt 4):811-24 PMID: 14985261
  61. Basal forebrain atrophy is a distinctive pattern in dementia with Lewy bodies.
    Neuroreport. 2004 Aug 6;15(11):1711-4 PMID: 15257132
  62. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects.
    Neuroimage. 2004 Sep;23(1):325-35 PMID: 15325380
  63. Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration.
    Arch Neurol. 2004 Oct;61(10):1579-84 PMID: 15477512
  64. Lewy body-related alpha-synucleinopathy in the aged human brain.
    J Neural Transm (Vienna). 2004 Oct;111(10-11):1219-35 PMID: 15480835
  65. Stages in the development of Parkinson's disease-related pathology.
    Cell Tissue Res. 2004 Oct;318(1):121-34 PMID: 15338272
  66. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
    J Psychiatr Res. 1975 Nov;12(3):189-98 PMID: 1202204
  67. Production and suppression of tremor by mesencephalic tegmental lesions in monkeys.
    Exp Neurol. 1979 Jun;64(3):516-27 PMID: 111960
  68. A new clinical scale for the staging of dementia.
    Br J Psychiatry. 1982 Jun;140:566-72 PMID: 7104545
  69. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.
    J Comp Neurol. 1983 Feb 20;214(2):170-97 PMID: 6841683
  70. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
    Neurology. 1984 Jul;34(7):939-44 PMID: 6610841
  71. Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients.
    Acta Neuropathol. 1987;75(1):8-15 PMID: 3434218
  72. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase.
    J Comp Neurol. 1988 Sep 8;275(2):216-40 PMID: 3220975
  73. Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.
    J Neurochem. 1990 Oct;55(4):1454-6 PMID: 1697897
  74. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness.
    Brain Cogn. 1995 Aug;28(3):240-58 PMID: 8546852
  75. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease.
    Neurology. 1998 Oct;51(4):993-9 PMID: 9781519
  76. Complex visual hallucinations. Clinical and neurobiological insights.
    Brain. 1998 Oct;121 ( Pt 10):1819-40 PMID: 9798740
  77. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies.
    Neurology. 1999 Apr 12;52(6):1153-8 PMID: 10214736
  78. Cholinergic markers in elderly patients with early signs of Alzheimer disease.
    JAMA. 1999 Apr 21;281(15):1401-6 PMID: 10217056
  79. Functional imaging of Parkinson's disease: is it possible to detect brain areas for specific symptoms?
    J Neural Transm Suppl. 1999;56:139-53 PMID: 10370908
  80. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
    J Neural Transm (Vienna). 1999;106(5-6):525-35 PMID: 10443555
Article Info
Journal
Brain : a journal of neurology
Abbr.
Brain
ISSN
1460-2156
Published
2007-03-00
Epub
2007-00-31
Pages
708-19
Language
English
Region
England
NLM ID
0372537
PMCID
PMC2730778
Subset
IM
Grants
NIA NIH HHS · P50 AG16574 · United States
NIA NIH HHS · R01 AG11378 · United States
NIA NIH HHS · U01 AG006786-23 · United States
NIA NIH HHS · P50 AG016574 · United States
NICHD NIH HHS · K12)-HD49078 · United States
NIA NIH HHS · R01 AG015866 · United States
NIA NIH HHS · R01 AG011378 · United States
NIA NIH HHS · R01 AG011378-15 · United States
NIA NIH HHS · P50 AG016574-080004 · United States
NIA NIH HHS · R01 AG015866-09 · United States
NIA NIH HHS · U01 AG06786 · United States
NIA NIH HHS · R01 AG15866 · United States
NICHD NIH HHS · K12 HD049078 · United States
NIA NIH HHS · U01 AG006786 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com